BlackRock Institutional Trust’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
GE
FLAM
NCGI
GIM
CRC
DCM
BFA
BlackRock Institutional Trust's NEO Position: Q4 2016 in Review
BlackRock Institutional Trust increased its NeoGenomics (NEO) stake by 16% in Q4 2016, buying an estimated $1.91M and bringing the position to 1,589,352 shares worth $13.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2219.
BlackRock Institutional Trust first reported a position in NEO in Q2 2013 and has held it in 14 quarters since. 143 funds tracked by Wall St. Rank hold NEO as of Q4 2016.
- BlackRock Institutional Trust held 1,589,352 shares of NeoGenomics worth $13.6M as of Q4 2016.
- BlackRock Institutional Trust bought 222,432 NeoGenomics shares in Q4 2016, an estimated $1.91M.
- NeoGenomics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2219 holding.
- BlackRock Institutional Trust first reported a position in NeoGenomics in Q2 2013 and has held it in 14 quarters since.
- 143 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.